Molecular Imaging: Page 276

CMS committee not yet swayed on brain amyloid PET imaging

By Wayne Forrest

A U.S. Centers for Medicare and Medicaid Services (CMS) advisory committee said on Wednesday that more studies are needed to confirm the efficacy of Eli Lilly and Avid Radiopharmaceuticals' Amyvid radiopharmaceutical for brain beta-amyloid PET imaging.

January 30, 2013

PET/CT predicts response to endorectal radiotherapy

By Eric Barnes

PET/CT results can predict which patients will respond to high-dose-rate endorectal brachytherapy for stage II and III rectal cancer, according to a study presented at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium. The results could pave the way for easier treatments and better outcomes.

January 29, 2013

Navidea to raise $4.8M in financing

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals has initiated a sale of common stock to raise approximately $4.8 million toward its ongoing operations.

January 29, 2013

PET MPI with flurpiridaz F-18 tops SPECT MPI

By Wayne Forrest

PET myocardial perfusion imaging (MPI) with flurpiridaz F-18 is "safe and superior" to SPECT MPI with technetium-99m for image quality, interpretation, coronary artery disease diagnosis, and patient tolerance of the tracer, according to a study published in the January 29 issue of the Journal of the American College of Cardiology.

January 29, 2013

PET/MRI at Arab Health; new amyloid PET guidelines; racial disparity in colon cancer treatment

By Brian Casey

January 28, 2013

MDCT falls short in finding myocardial ischemia

By Wayne Forrest

In a comparison of patients with ischemia detected by SPECT or PET myocardial perfusion imaging, resting electrocardiogram-gated 64-slice MDCT proved "unsuitable" for clinical use, according to a study published in the February issue of the American Journal of Roentgenology.

January 28, 2013

Arab Health: Is PET/MRI really worth the extra cost?

By Philip Ward

DUBAI - Most PET/MR systems cost between $5 million and $7 million U.S., whereas a new generation PET/CT machine with 128 detectors costs between $1.5 million and $2 million U.S. Is PET/MR worth the extra dollars, asks a global expert on hybrid imaging at Arab Health.

January 27, 2013

Joint task force publishes brain amyloid PET criteria

By Wayne Forrest

A task force assembled by the Society of Nuclear Medicine and Molecular Imaging and the Alzheimer's Association has concluded that brain amyloid PET imaging could potentially help diagnose individuals with cognitive impairment if certain conditions are met.

January 27, 2013

Samsung purchases NeuroLogica

By AuntMinnie.com staff writers

Samsung Electronics America has continued its push to increase its medical equipment presence by acquiring portable scanner developer NeuroLogica.

January 27, 2013

Lantheus names Bailey new president/CEO

By AuntMinnie.com staff writers

Diagnostic imaging agent developer Lantheus Medical Imaging has named Jeffrey Bailey as the company's new president and CEO.

January 24, 2013

FDDNP-PET shows toll of concussions on retired NFL players

By Wayne Forrest

For the first time, using the radiopharmaceutical FDDNP with PET, researchers at the University of California, Los Angeles have identified abnormal tau proteins associated with repetitive head injury in five former professional football players, according to a study in the American Journal of Geriatric Psychiatry.

January 21, 2013

MIM updates MIMneuro software

By AuntMinnie.com staff writers

Medical imaging software developer MIM Software has introduced version 5.6 of its MIMneuro software.

January 21, 2013

Previous Page

Page 276 of 612

Next Page